Synthesis and biological evaluation of DL-4,4-difluoroglutamic acid and DL-gamma,gamma-difluoromethotrexate.
T Tsukamoto, T Kitazume, J J McGuire, J K Coward
Index: J. Med. Chem. 39(1) , 66-72, (1996)
Full Text: HTML
Abstract
DL-4,4-Difluoroglutamic acid (DL-4,4-F2Glu) and its methotrexate analogue, DL-gamma,gamma-difluoromethotrexate (DL-gamma,gamma-F2MTX), were synthesized and evaluated as alternate substrates or inhibitors of folate-dependent enzymes. Synthesis of DL-4,4-F2Glu involved the nitroaldol reaction of ethyl nitroacetate with a difluorinated aldehyde ethyl hemiacetal as a key step. Attempted ligation of DL-4,4-F2Glu to methotrexate (MTX), catalyzed by human folylpoly-gamma-glutamate synthetase (FPGS), revealed that DL-4,4-F2Glu is a poor alternate substrate. DL-gamma,gamma-F2MTX was synthesized by a route proceeding through N-[4-(methylamino)benzoyl]-4,4-difluoroglutamic acid di-tert-butyl ester followed by alkylation with 6-(bromomethyl)-2,4-pteridinediamine hydrobromide. DL-gamma,gamma-F2MTX was found to be neither a substrate nor an inhibitor of human FPGS. The fluorinated analogue of MTX, however, inhibits DHFR and cell growth with the same potency as MTX.
Related Compounds
Related Articles:
1980-07-01
[Gig. Tr. Prof. Zabol. (7) , 49-51, (1980)]
2010-11-05
[J. Org. Chem. 75(21) , 7435-8, (2010)]
2003-12-12
[J. Org. Chem. 68(25) , 9854-7, (2003)]
2005-01-01
[Nucleosides Nucleotides Nucleic Acids 24(5-7) , 1043-6, (2005)]
2012-02-13
[Chemistry 18(7) , 2081-93, (2012)]